Table: SymBio Pharmaceuticals - Q1 parent results

SymBio Pharmaceuticals

11/05/2017 07:30

May 11 (Reuters)-  
             SymBio Pharmaceuticals Limited  
             PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended        Year to   
                Mar 31, 2017        Mar 31, 2016      Dec 31, 2017   
                   LATEST             YEAR-AGO           LATEST      
                   RESULTS             RESULTS          FORECAST     
  Sales            869 mln             193 mln            2.90       
                (+350.1 pct)         (-52.7 pct)       (+22.6 pct)   
  Operating     loss 525 mln        loss 518 mln        loss 3.24    
  Recurring     loss 583 mln        loss 655 mln        loss 3.30    
  Net           loss 582 mln        loss 652 mln        loss 3.31    
  EPS          loss 12.12 yen      loss 20.15 yen    loss 71.07 yen  
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
   
  NOTE - SymBio Pharmaceuticals Limited.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T 
  ((Tokyo Headline News Desk +813 6441 1812))